Latest filing published 11 Sept 2026 for Aurinia Pharmaceuticals Inc., €164k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stephen P. Robertson is a declared insider of Aurinia Pharmaceuticals Inc. (board member), with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 2 March 2022 to 10 September 2026.
No open-market purchase appears, only 4 sales worth €928k. Other entries cover 7 share grants. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 11 September 2026 with an open-market sale (€164k) in Aurinia Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations